BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37047005)

  • 1. Cholesterol Is a Regulator of CAV1 Localization and Cell Migration in Oral Squamous Cell Carcinoma.
    Chan NN; Yamazaki M; Maruyama S; Abé T; Haga K; Kawaharada M; Izumi K; Kobayashi T; Tanuma JI
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 Expression at Metastatic Lymph Nodes Predicts Unfavorable Outcome in Patients with Oral Squamous Cell Carcinoma.
    Kato K; Miyazawa H; Kobayashi H; Noguchi N; Lambert D; Kawashiri S
    Pathol Oncol Res; 2020 Oct; 26(4):2105-2113. PubMed ID: 31907776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
    Zhai J; Luo G
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral Squamous Cell Carcinoma-Derived Cell-Free DNA Modulates Stemness and Migration of Oral Squamous Cell Carcinoma Cell Line by Inducing M2 Macrophage Polarization].
    Zheng SZ; Meng L; Ren FL; Ren CX; Li X; Wang DD; Sun HC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):510-516. PubMed ID: 37248576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma.
    Pal SK; Nguyen CT; Morita KI; Miki Y; Kayamori K; Yamaguchi A; Sakamoto K
    J Oral Pathol Med; 2016 Nov; 45(10):730-739. PubMed ID: 26850833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho/ROCK Pathway Regulates Migration and Invasion of Esophageal Squamous Cell Carcinoma by Regulating Caveolin-1.
    Liu Z; Yu J; Wu R; Tang S; Cai X; Guo G; Chen S
    Med Sci Monit; 2017 Dec; 23():6174-6185. PubMed ID: 29288243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA_0076977 contributes to oral squamous cell carcinoma progression through mediating microRNA-802 axis.
    Hei N; Chen Y; Peng S; Bao Y; Jin L
    Arch Oral Biol; 2022 Dec; 144():105567. PubMed ID: 36265392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.
    Huang CF; Yu GT; Wang WM; Liu B; Sun ZJ
    Int J Clin Exp Pathol; 2014; 7(9):6032-9. PubMed ID: 25337248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
    Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
    Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Caveolin-1 Expression in Tumor Cells is Associated with Increased Aggressiveness and Cell Invasion in Oral Squamous Cell Carcinoma.
    Nascimento RB; Paiva KBS; Risteli M; Silva LHS; Rodini CO; Rodrigues MFSD; De Cicco R; Lopez RVM; Salo TA; Nunes FD; Xavier FCA
    Head Neck Pathol; 2023 Sep; 17(3):618-630. PubMed ID: 37233885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
    Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
    J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol depletion affects caveolin-1 expression, migration and invasion of oral tongue squamous cell carcinoma cell lines.
    Nascimento RB; Risteli M; Paiva KBS; Juurikka K; Rodrigues MFSD; Salo TA; Xavier FCA
    Arch Oral Biol; 2023 Jun; 150():105675. PubMed ID: 36989864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.